Keeping breast cancer at bay. Women at risk are asked to weigh the pros and cons of a prevention pill.
作者信息
Brink S
出版信息
US News World Rep. 1999 May 31;126(21):76.
PMID:10387894
Abstract
摘要
相似文献
1
Keeping breast cancer at bay. Women at risk are asked to weigh the pros and cons of a prevention pill.
US News World Rep. 1999 May 31;126(21):76.
2
Breast Cancer Prevention Trial shows major benefit, some risk.
Jpn J Clin Oncol. 1998 Jun;28(6):417-8.
3
Women's decision making about whether or not to use breast cancer chemoprevention.
Women Health. 2005;41(2):81-95. doi: 10.1300/J013v41n02_06.
4
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62. doi: 10.1093/jnci/dji372.
5
Tamoxifen and breast cancer prevention: what should you tell your patients?
CMAJ. 1998 Jun 16;158(12):1615-7.
6
The current status of breast cancer chemoprevention: a star is born.
J Surg Oncol. 2007 Jan 1;95(1):4-5. doi: 10.1002/jso.20658.
7
8
The cost effectiveness of tamoxifen in the prevention of breast cancer.
Am J Manag Care. 1999 Jun;5(6 Suppl):S389-406.
9
Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2210-2. doi: 10.1158/1055-9965.EPI-06-1065.
10
DM effort seeks to improve outcomes through prevention, early detection of breast cancer.
Dis Manag Advis. 2000 Sep;6(9):140-4, 132.
Zotero 插件